Fig. 6From: The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathwaySerum levels of IL-10 and IL-33. ELISA results of A IL-10 and B IL-33 levels in the serum. The results are expressed as the meanāĀ±āSD (nā=ā10 per group). *Pā<ā0.05Back to article page